Neutropenia: Etiology and Pathogenesis

Clinical Cornerstone

Volumn 8, Issue SUPPL. 5, 2006, Pages

  Schwartzberg, Lee S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENAZONE; ANALGESIC AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; GOLD DERIVATIVE; GRANULOCYTE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LEUKOCYTE ELASTASE; PENICILLIN G; PROPYLTHIOURACIL; SALAZOSULFAPYRIDINE; TICLOPIDINE; VALPROIC ACID;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; AGRANULOCYTOSIS; ARTICLE; BACTERIAL INFECTION; BARTH SYNDROME; BONE MARROW; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DESTRUCTION; CHEDIAK HIGASHI SYNDROME; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; DYSKERATOSIS CONGENITA; FEBRILE NEUTROPENIA; GASTROINTESTINAL INFECTION; GENE MUTATION; GRAM NEGATIVE BACTERIUM; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LOW DRUG DOSE; MORBIDITY; MORTALITY; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NEUTROPHIL COUNT; PATHOGENESIS; RISK ASSESSMENT; SHWACHMAN SYNDROME; SKIN INFECTION; STAPHYLOCOCCUS;

EID: 33947205245     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1098-3597(06)80053-0     Document Type: Article

References (31)

1. Bodey G., Buckley M., Sathe Y., et al. Quantitative relationships between circulating leukocytes and infection in patients with leukemia. Ann Intern Med 64 (1966) 328-340
2. Dale D.C., Bolyard A.A., and Aprilyan A. Cyclic neuropenia. Semin Hematol. 3 (2002) 89-94
3. Hammond IV W.P., Price T.H., Souza L.M., et al. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 320 (1989) 1306-1311
4. Bellanné-Chantelot C., Clauin S., Leblanc T., et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: A study of 81 patients from the French Neutropenia Register. Blood 103 (2004) 4119-4125
5. Dale D.C., Cottle T.E., Fier C.J., et al. Severe chronic neutropenia: Treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 72 (2003) 82-93
6. Bux J., Behems G., Jaeger G., et al. Diagnosis and clinical course of autounmune neutropenia in infancy: Analysis of 240 cases. Blood 91 (1998) 181-186
7. Logue G.L., Shastri K.A., Laughlin M., et al. Idiopathic neutropenia: Antineutrophil antibodies and clinical correlations. Am J Med 90 (1991) 211-216
8. Strakebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 39 (2002) 121-127
9. Berliner N., Horwitz M., and Loughran Jr. T.P. Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program (2004) 63-79
10. Loughran T. Clinical disease of large granular lymphocytes. Blood 82 (1993) 1-14
11. Starkebaum G., Loughran T., Gaur L., et al. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lympho cytes in rheumatoid arthritis. Arthritis Rheum 40 (1997) 624-626
12. Jain K.K. Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 31 (1994) 213-215
13. Eular H.H., Harten P., Zuener R.A., et al. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infection. J Rheumatol 24 (1997) 2153-2157
14. Papadaki H.A., Pontikoglou C., Eliopoulos D.G., et al. Helicobacter pylori infection is probably the cause of chronic idiopathic neutropenia (CIN)-associated splenomegaly. Am J Hematol 81 (2006) 142-144
15. Papadaki H.A., Eliopoulos A.G., Kosteas T., et al. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood 101 (2003) 2591-2600
16. Papadaki H.A., Coulocheri S., Eliopoulos GD., et al. Patients with chronic idiopathic neutropenia of adults have increased serum concentrations of inflammatory cytokines and chemokines. Am J Hematol 65 (2000) 271-277
17. Kracke R.R. Recurrent agranulocytosis. Am J Clin Pathol 1 (1931) 385
18. Hematology and oncology: Leukopenia and lymphocytopenia. In: Beers M.I.L., and Berkow R. (Eds). The Merck Manual of Diagnosis and Therapy. 17th ed. (1999), Merck & Co, Inc, Whitehouse Station, NJ 847-1000
19. Salama A., Schutz B., Kiefel V., et al. Immune mediated agranulocytosis related to drugs and their metabolites: Mode of sensitization and heterogeneity of antibodies. Br J Haematol 72 (1989) 127-132
20. Murphy M.F., Chapman I.F., Metcalf P., et al. Antibiotic induced neutropenia. Lancet 2 (1985) 1306-1307
21. Bhatt V., and Saleem A. Drug-induced neutropenia-pathophysiology, clinical features, and management. Ann Clin Lab Sci 34 (2004) 131-137
22. Bottiger L., Furhoff A., and Holmberg L. Drug-induced blood dyscrasias. A ten year material from the Swedish Adverse Drug Reaction Committee. Acta Med Scand 205 (1979) 457-461
23. Kaufman D., Kelly J., Levy M., et al. The drug etiology of agranulocytosis and aplastic anemia. Epidemiology and Biostatistics Vol 18 (1991), Oxford University Press, New York, NY
24. Klastersky J., Paesmans M., Rubenstein E.B., et al. The Multinational Association for Supportive Care in Cancer Risk Index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18 (2000) 3038-3051
25. Leong D.C., Kinlay S., Ackland S., et al. Low-risk neutropenia in a medical oncology unit. Aust N Z J Med 27 (1997) 403-407
26. Chang J. Chemotherapy dose reduction and delay in clinical practice: Evaluating the risk to patient outcome in adjuvant chemotherapy to breast cancer. Eur J Cancer 36 (2000) S11-S14
27. Lyman G. Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: A review of the evidence. J Natl Compr Canc Netw 3 (2005) 557-571
28. Crighton M., and Puppione A. Geriatric neutrophils: Implications for older adults. Semin Oncol Nursing 22 (2006) 3-9
29. Smith T., Khatcheressian J., Lyman G., et al. 2006 Update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 24 (2006) 3187-3205
30. Drenick E., and Alvarez L. Neutropenia in prolonged fasting. Am J Clin Nutr 24 (1971) 859-863
31. Rosen E.U., Geefhuysen J., Anderson R., et al. Leucocyte function in children with kwashiorkor. Arch Dis Child 50 (1975) 220-224